Lawsuits Filed by Patients Affected by Xarelto Side Effects

Xarelto (rivaroxaban) has been a subject of various media reports due to the increasing complaints of its users. Xarelto is one of the newest blood thinners on the market and is manufactured by Bayer and marketed by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals.In most cases, people who suffer serious side effects from Xarelto incur medical debt from emergency visits to the hospital and the cost of ongoing care. Time spent recovering from side effects can also cause financial hardship because of lost wages and time away from work. With this, the affected patients file Xarelto lawsuits against its manufacturer to acquire due compensation from the injuries they have suffered. The webpage http://www.xareltolawsuit.us discusses more about this.

Approved by the U.S. Food and Drug Administration (FDA) in 2011, Xarelto has been linked to a number of life-threatening side effects. The most dangerous side effect of Xarelto is uncontrollable bleeding. This is a risk shared by all blood thinners. 

Xarelto was originally approved by the FDA for the prevention of a type of blood clot known as deep vein thrombosis (DVT). It is a condition that commonly occurs after certain types of surgeries. The drug is also commonly prescribed to lessen the risk of stroke in patients with a certain type of heart rhythm disorder. 

According to medical resources, Xarelto is one of a newer types of anticoagulants that are hyped to be safer with less monitoring required. However, unlike other anticoagulants, Xarelto does not have an FDA-approved reversal agent to quickly stop the drug’s blood thinning effects. Reports say that doctors have been using emergency treatments to stop Xarelto’s bleeding side effects in an attempt to avoid serious injuries and deaths.

The FDA recently rejected Xarelto use for the treatment of acute coronary syndrome. The agency explained that the drug manufacturers failed to show that the Xarelto was both safe and effective. This was the third instance that the FDA had rejected to expand Xarelto’s approved use.

Generally, Xarelto lawsuits allege that the drug causes brain hemorrhaging, rectal bleeding, intestinal bleeding and death caused by uncontrollable bleeding. These lawsuits also accuse the defendant company of concealing important safety information and not testing the drug enough before it was put on the market. 

References:

reuters.com/article/2014/06/14/us-bayer-suit-idUSKBN0EP0HW20140614

pharmatimes.com/Article/14-02-17/FDA_rejects_Bayer_J_J_s_Xarelto_again.aspx

medicaldaily.com/blood-thinner-xarelto-blamed-deaths-and-serious-injuries-lawsuit-276604